In addition to promoting tumor killing, IFNγ also upregulates PD-L1 expression on tumor cells, which, in turn, inhibits the effector function of CTLs by interacting with PD1 on CTLs [34, 35]. The gene discussed is PDCD1; the disease is neoplasm.